Comparison of Double Contrast-Enhanced Ultrasound and MDCT for Assessing Vascular Involvement of Pancreatic Adenocarcinoma: Preliminary Results Correlated with Surgical Findings

Abstract

Purpose: To investigate the accuracy of double contrast-enhanced ultrasound (DCEUS) for assessing vascular involvement by pancreatic adenocarcinoma.

Materials and Methods: 38 patients with pancreatic adenocarcinoma proven by postoperative pathology or biopsy were enrolled in this study. DCEUS (intravenous microbubbles combined with an oral contrast agent) and 16-row multi-detector CT (MDCT) were performed preoperatively to assess vascular invasion by pancreatic adenocarcinoma. The diagnostic accuracy of DCEUS and MDCT for assessing vascular involvement was calculated and compared. ROC curves were used to evaluate the diagnostic confidences of the two methods. The inter- and intra-observer reliability of DCEUS for assessing vascular invasion was investigated in the present study.

Results: Almost perfect agreement between DCEUS and MDCT was obtained using Kappa analysis (k = 0.83, p = 0.000). Compared with surgical findings, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy of peripancreatic vascular invasion were 66.67 %, 100 %, 100 %, 60 %, and 77.78 %, respectively, for DCEUS and 75 %, 100 %, 100 %, 66.67 %, and 83.33 %, respectively, for MDCT. There was no significant difference in accuracy between DCEUS and MDCT for evaluating peripancreatic vascular invasion (p = 0.108). The combination of DCEUS and MDCT increased the diagnostic confidence in assessing peripancreatic vascular invasion with an area under ROC curve from 0.83 for DCEUS (p = 0.025) and 0.88 for MDCT (p = 0.011) to 0.92 for both combined (p = 0.005). The intra- and inter-observer reproducibility were both almost perfect for assessing the peripancreatic vascular invasion by DCEUS with a Kappa value of 0.94 (p = 0.000) for intra-observer and 0.83 (p = 0.000) for inter-observer.

Conclusion: DCEUS could be considered as a reliable and accurate method for evaluating the peripancreatic vascular invasion of pancreatic adenocarcinoma.

Zusammenfassung

Ziel: Die Untersuchung der Genauigkeit des doppelt kontrastverstärkten Ultraschalls (DCEUS) zur der Bewertung der Gefäßbeteiligung beim duktalen Adenokarzinom des Pankreas.

Material und Methoden: 38 Patienten mit einem durch postoperative Pathologie oder Biopsie diagnostizierten Adenokarzinom des Pankreas wurden in die Studie aufgenommen. DCEUS (intravenöse Mikrobläschen in Kombination mit einem oralen Kontrastmittel) und eine 16-Zeilen-Multidetektor-Computertomografie (MDCT) wurden präoperativ durchgeführt, um die Gefäßinvasion bei Pankreaskarzinomen zu bewerten. Die diagnostische Genauigkeit von DCEUS und MDCT zur Bewertung der Gefäßbeteiligung wurde berechnet und miteinander verglichen. ROC-Kurven wurden eingesetzt, um die diagnostische Güte der beiden Methoden zu bewerten. Die Inter- und Intraobserver-Reliabilität von DCEUS bei der Bewertung der Gefäßinvasion wurde in der vorliegenden Studie untersucht.

Ergebnisse: Ein ausgezeichnete Übereinstimmung zwischen DCEUS und MDCT wurde bei der Kappa-Analyse erzielt (k = 0,83; p = 0,000). Im Vergleich zu den chirurgischen Befunden betrug die Sensitivität von DCEUS bei der Bewertung der peripankreatischen Invasion 66,67 %, die Spezifität 100 %, der positive Vorhersagewert (PVW) 100 % und negative Vorhersagewert (NVW) 60 %. Bei der MDCT betrug die Sensitivität 75 %, die Spezifität 100 %, der PVW 66,67 % und der NVW 83,33 %. Bei der Bewertung der peripankreatischen Invasion gab es keinen signifikanter Unterschied der Genauigkeiten von DCEUS und MDCT (p = 0,108). Die Kombination von DCEUS und MDCT zur Bestimmung der peripankreatischen Invasion führte zu einer höheren diagnostischen Güte mit einer Fläche unter der ROC-Kurve von 0,83 für DCEUS (p = 0,025) und 0,88 für MDCT (p = 0,011) alleine und 0,92 für beide in Kombination (p = 0,005). Sowohl die Intra- als auch die Interobserver-Reproduzierbarkeit für DCEUS bei der Bewertung der peripankreatischen Gefäßinvasion waren nahezu perfekt mit einem Kappa-Wert von 0,94 (p = 0,000) für die Intraobserver- und von 0,83 (p = 0,000) für die Interobserver-Reproduzierbarkeit.

Schlussfolgerung: DCEUS kann als verlässliche und genaue Methode zur Bewertung der peripankreatischen Gefäßinvasion bei Adenokarzinomen des Pankreas in Betracht gezogen werden.

Key words

abdomen - contrast agents - ultrasound

• References

• 1 Jemal A, Siegel R, Xu J et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300
• 2 Niederhuber JE, Brennan MF, Menck HR. The national cancer data base report on pancreatic cancer. Cancer 1995; 76: 1671-1677
• 3 Kuwahara K, Sasaki T, Kuwada Y et al. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas 2003; 26: 344-349
• 4 Piscaglia F, Lencioni R, Sagrini E et al. Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol 2010; 36: 531-550
• 5 D'Onofrio M, Malagò R, Zamboni G et al. Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 2005; 5: 398-402
• 6 Piscaglia F, Nolsøe C, Dietrich CF et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications. Ultraschall in Med 2011; DOI: 10.1055/s-0031-1281676.
• 7 Böttger TC, Boddin J, Düber C et al. Diagnosing and staging of pancreatic carcinoma-what is necessary?. Oncology 1998; 55: 122-129
• 8 Shiyan L, Pintong H, Zongmin W et al. The relationship between enhanced intensity and microvessel density of gastric carcinoma using double contrast-enhanced ultrasonography. Ultrasound Med Biol 2009; 35: 1086-1091
• 9 Zheng Z, Yu Y, Lu M et al. Double contrast-enhanced ultrasonography for the preoperative evaluation of gastric cancer: A comparison to endoscopic ultrasonography with respect to histopathology. Am J Surg 2011; 202: 605-611
• 10 Vargas R, Nino-Murcia M, Trueblood W et al. MDCT in Pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. Am J Roentgenol 2004; 182: 419-425
• 11 Greene FL, Page DL, Fleming ID et al. (eds) AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002: 157-164
• 12 Phillips P, Gardner E. Contrast-agent detection and quantification. Eur Radiol 2004; 14: P4-P10
• 13 Wu B, Song B. Curved planar reformations in multi-slice spiral CT in pancreatic adenocarcinoma: prediction of invasion of pancreatic and peripancreatic ductal structures. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006; 28: 71-75
• 14 Imbriaco M, Megibow AJ, Camera L et al. Dual-phase versus single-phase helical CT to detect and assess resectability of pancreatic carcinoma. Am J Roentgenol 2002; 178: 1473-1479
• 15 D'Onofrio M, Zamboni GA, Malagò R et al. Resectable pancreatic adenocarcinoma: is the enhancement pattern at contrast-enhanced ultrasonography a pre-operative prognostic factor?. Ultrasound Med Biol 2009; 12: 1929-1937
• 16 Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33: 363-374
• 17 Kitano M, Kudo M, Maekawa K et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 2004; 53: 854-859
• 18 Masaki T, Ohkawa S, Amano A et al. Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer 2005; 103: 1026-1035
• 19 Takeshima K, Kumada T, Toyoda H et al. Comparison of IV contrast-enhanced sonography and histopathology of pancreatic cancer. Am J Roentgenol 2005; 185: 1193-1200
• 20 D'Onofrio M, Zamboni G, Tognolini A et al. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 2006; 12: 4181-4184
• 21 Dietrich CF, Braden B, Hocke M et al. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol 2008; 134: 635-643
• 22 D'Onofrio M, Zamboni G, Faccioli N et al. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 2007; 32: 171-181
• 23 Faccioli N, D'Onofrio M, Malagò R et al. Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas 2008; 37: 265-268
• 24 D'Onofrio M, Megibow AJ, Faccioli N et al. Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. Am J Roentgenol 2007; 189: 1435-1442
• 25 D'Onofrio M, Barbi E, Dietrich CF et al. Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol 2011; DOI: 10.1016/j.ejrad.2011.01.053.
• 26 Lu DS, Reber HA, Krasny RM et al. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. Am J Roentgenol 1997; 168: 1439-1443
• 27 Klauss M, Schöbinger M, Wolf I et al. Value of three-dimensional reconstructions in pancreatic carcinoma using multidetector CT: initial results. World J Gastroenterol 2009; 15: 5827-5832
• 28 Dietrich CF, Kratzer W, Strobe D et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699-1705
• 29 Olivié D, Lepanto L, Billiard JS et al. Predicting resectability of pancreatic head cancer with multi-detector CT. Surgical and pathologic correlation. JOP 2007; 8: 753-758